The S&P 500 enters its weakest seasonality stretch of the year in May.
The Surprising Reason Stocks Are Defying ‘Sell in May’
Leave a Comment
You Might Also Like
No Fasting, No Injections: Inside Eli Lilly’s New Weight‑Loss Drug
The new weight loss drug hasn’t even been formally promoted yet, its CEO says.
Want to Raise Happier Kids? Parenting Research Says 1 Simple Approach Works Best
Constructive feedback is helpful, but positive feedback is great.
MIT Sloan Management Review to Cease Publication
The venerable business magazine and website, a key chronicler of tech and management insights, is shutting down after 67 years.…
Elon Musk Took Home $0 From Tesla in 2025
Despite a reported $158.4 billion compensation figure, Tesla’s CEO didn’t earn a dime last year as his pay remains tied…
